Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer
JNCI: Journal of the National Cancer Institute · 2024
DOI: 10.1093/jnci/djae089 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Jing Sun und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Big Data in Health Science School of Public Health, and Center of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zh…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Genome-Wide Association Study, Quantitative Trait Loci, Mendelian Randomization Analysis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Fund for Distinguished Young Scholars of Zhejiang Province, National Nature Science Foundation of China, Swedish Cancer Society.
Abstract (Originalsprache)
Background
We aimed to identify plasma and urinary metabolites related to colorectal cancer (CRC) risk and elucidate their mediator role in the associations between modifiable risk factors and CRC.
Methods
Metabolite quantitative trait loci were derived from 2 published metabolomics genome-wide association studies, and summary-level data were extracted for 651 plasma metabolites and 208 urinary metabolites. Genetic associations with CRC were obtained from a large-scale genome-wide association study meta-analysis (100 204 cases, 154 587 controls) and the FinnGen cohort (4957 cases, 304 197 controls). Mendelian randomization and colocalization analyses were performed to evaluate the causal roles of metabolites in CRC. Druggability evaluation was employed to prioritize potential therapeutic targets. Multivariable Mendelian randomization and mediation estimation were conducted to elucidate the mediating effects of metabolites on the associations between modifiable risk factors and CRC.
Results
The study identified 30 plasma metabolites and 4 urinary metabolites for CRC. Plasma sphingomyelin and urinary lactose, which were positively associated with CRC risk, could be modulated by drug interventions (ie, olipudase alfa, tilactase). Thirteen modifiable risk factors were associated with 9 metabolites, and 8 of these modifiable risk factors were associated with CRC risk. These 9 metabolites mediated the effect of modifiable risk factors (Actinobacteria, body mass index, waist to hip ratio, fasting insulin, smoking initiation) on CRC.
Conclusion
This study identified key metabolite biomarkers associated with CRC and elucidated their mediator roles in the associations between modifiable risk factors and CRC. These findings provide new insights into the etiology and potential therapeutic targets for CRC and the etiological pathways of modifiable environmental factors with CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Big Data in Health Science School of Public Health, and Center of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK.
- Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- Department of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
- Unit of Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
ORCID-Profile: Jing Sun, Shuai Yuan, Xue Li
Förderung
- Natural Science Fund for Distinguished Young Scholars of Zhejiang Province
- National Nature Science Foundation of China
- Swedish Cancer Society
- Swedish Heart-Lung Foundation
- Hjärt-Lungfonden
- Swedish Research Council
- Vetenskapsrådet
- CRUK Career Development
Zitieren
APA
Sun, J., Zhao, J., Zhou, S., Li, X., Li, T., Wang, L., Yuan, S., Chen, D., Law, P. J., Larsson, S. C., Farrington, S. M., Houlston, R. S., Dunlop, M. G., Theodoratou, E., & Li, X. (2024). Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae089
Vancouver
Sun J, Zhao J, Zhou S, Li X, Li T, Wang L, et al. Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae089
BibTeX
@article{Sun2024,
author = {Sun, Jing and Zhao, Jianhui and Zhou, Siyun and Li, Xinxuan and Li, Tengfei and Wang, Lijuan and Yuan, Shuai and Chen, Dong and Law, Philip J and Larsson, Susanna C and Farrington, Susan M and Houlston, Richard S and Dunlop, Malcolm G and Theodoratou, Evropi and Li, Xue},
title = {Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2024},
doi = {10.1093/jnci/djae089}
}
EUVIMED